Prediction of esophagogastroduodenoscopy therapeutic usefulness for in-ICU suspected upper gastrointestinal bleeding: the SUGIBI score study - Université Paris Cité
Article Dans Une Revue Annals of Intensive Care Année : 2024

Prediction of esophagogastroduodenoscopy therapeutic usefulness for in-ICU suspected upper gastrointestinal bleeding: the SUGIBI score study

Thibault Vieille
  • Fonction : Auteur
Tomas Urbina
  • Fonction : Auteur
Vincent Bonny
  • Fonction : Auteur
Paul Gabarre
  • Fonction : Auteur
Louai Missri
  • Fonction : Auteur
Maxime Gasperment
  • Fonction : Auteur
Jean-Luc Baudel
  • Fonction : Auteur
Nicolas Carbonell
  • Fonction : Auteur
Alexandra Beurton
  • Fonction : Auteur
Sayma Chaibi
  • Fonction : Auteur
Aurélia Retbi
  • Fonction : Auteur
Muriel Fartoukh
  • Fonction : Auteur
Gaël Piton
  • Fonction : Auteur
Bertrand Guidet
  • Fonction : Auteur
Eric Maury
  • Fonction : Auteur
  • PersonId : 897445
  • IdRef : 113128274

Résumé

Background: Suspected upper gastrointestinal bleeding (SUGIB) is a common issue during ICU stay. In the absence of specific guidelines on the indication and timing of esophagogastroduodenoscopy (EGD), there is substantial variability in EGD indication depending on accessibility and clinical presentation. This study aimed to investigate factors associated with the need for per-EGD hemostatic therapy and to create a score predicting therapeutic benefit of emergency bedside EGD in ICU patients with SUGIB.
Methods: We conducted a retrospective study in our ICU to identify factors associated with the need for hemostatic procedure during EGD performed for SUGIB. From this observational cohort, we derived a score predicting the need for hemostasis during EGD, the SUGIBI score. This score was subsequently validated in a retrospective multicenter cohort.
Results: Two hundred fifty-five patients not primarily admitted for GI bleeding who underwent a bedside EGD for SUGIB during their ICU stay were analyzed. The preeminent EGD indication were anemia (79%), melena (19%), shock (14%), and hematemesis (13%). EGD was normal in 24.7% of cases, while primary lesions reported were ulcers (23.1%), esophagitis (18.8%), and gastritis (12.5%). Only 12.9% of patients underwent hemostatic endotherapy during EGD. A SUGIBI score < 4 had a negative predictive value of 95% (91–99) for hemostatic endotherapy [AUC of 0.81; 0.75–0.91 ( p < 0.0001)]. The SUGIBI score for predicting the need for an EGD-guided hemostatic procedure was next validated in a multicenter cohort with an AUC of 0.75 (0.66–0.85) ( p < 0.0001), a score < 4 having a negative predictive value of 95% (92–97).
Conclusions Our study shows that the therapeutic usefulness of bedside emergency EGD for SUGIB in critically ill patients is limited to a minority of patients. The SUGIBI score should help clinicians stratify the probability of a therapeutic EGD.
Fichier principal
Vignette du fichier
13613_2024_Article_1250.pdf (1.38 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04589258 , version 1 (04-09-2024)

Licence

Identifiants

Citer

Victor Penaud, Thibault Vieille, Tomas Urbina, Vincent Bonny, Paul Gabarre, et al.. Prediction of esophagogastroduodenoscopy therapeutic usefulness for in-ICU suspected upper gastrointestinal bleeding: the SUGIBI score study. Annals of Intensive Care, 2024, 14 (1), pp.28. ⟨10.1186/s13613-024-01250-0⟩. ⟨hal-04589258⟩
33 Consultations
4 Téléchargements

Altmetric

Partager

More